Literature DB >> 20814816

Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer.

Cha Kyong Yom1, Dong-Young Noh, Woo Ho Kim, Hee Sung Kim.   

Abstract

Increased expression and activation of focal adhesion kinase (FAK) was reported to be an unfavorable factor in various human cancers, including breast cancer. In order to study FAK gene status as a prognostic factor, we evaluated FAK gene copy number and FAK protein expression in invasive breast cancer. Tumors from 435 patients with invasive breast cancer were evaluated for FAK gene status using fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) based on tissue array method. Survival analyses were performed using the Kaplan-Meier method in 267 patients. 42 out of 362 evaluable cases (11.6%) showed high polysomy and 22 cases (6.1%) had gene amplification by FISH. 108 out of 393 evaluable cases (27.5%) showed FAK overexpression by IHC. FAK FISH positivity was significantly associated with higher histologic grade, higher T stage, negative estrogen receptor expression, negative progesterone receptor expression and triple-negative phenotype; FAK overexpression with higher histologic grade and triple-negative phenotype. FAK overexpression was noted in 57.8% (37 of 64) of FAK FISH+ cases. The concordance of FISH and IHC results for FAK gene was observed in 74.9% (271 of 362). Survival analyses revealed the patients with FAK FISH+ breast cancer had significantly shorter overall survival and relapse-free survival compared to those with FISH- breast cancer. In node-positive breast cancer patients who received postoperative systemic treatment, the patients with FAK FISH+ showed significantly shorter 5-year survival rates. Despite of high significant concordance between the results of FISH and IHC for FAK gene in invasive breast cancer, only FAK FISH positivity was an unfavorable prognostic factor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20814816     DOI: 10.1007/s10549-010-1150-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  30 in total

1.  NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.

Authors:  Erik Hedrick; Syng-Ook Lee; Ravi Doddapaneni; Mandip Singh; Stephen Safe
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

Review 2.  Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance.

Authors:  Hassan Yousefi; Mousa Vatanmakanian; Mojdeh Mahdiannasser; Ladan Mashouri; Nikhilesh V Alahari; Mohammad Rafiee Monjezi; Shahrzad Ilbeigi; Suresh K Alahari
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

Review 3.  Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights.

Authors:  Hyunho Yoon; Joshua P Dehart; James M Murphy; Ssang-Taek Steve Lim
Journal:  J Histochem Cytochem       Date:  2014-11-07       Impact factor: 2.479

4.  Identification of new candidate therapeutic target genes in triple-negative breast cancer.

Authors:  Mathilde Glénisson; Sophie Vacher; Céline Callens; Aurélie Susini; Géraldine Cizeron-Clairac; Romuald Le Scodan; Didier Meseure; Florence Lerebours; Frédérique Spyratos; Rosette Lidereau; Ivan Bièche
Journal:  Genes Cancer       Date:  2012-01

5.  Mucinous carcinoma with micropapillary features is morphologically, clinically and genetically distinct from pure mucinous carcinoma of breast.

Authors:  Peng Sun; Zaixuan Zhong; Qianyi Lu; Mei Li; Xue Chao; Dan Chen; Wenyan Hu; Rongzhen Luo; Jiehua He
Journal:  Mod Pathol       Date:  2020-05-01       Impact factor: 7.842

6.  Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.

Authors:  Heath D Skinner; Uma Giri; Liang Yang; Sang Hyeok Woo; Michael D Story; Curtis R Pickering; Lauren A Byers; Michelle D Williams; Adel El-Naggar; Jing Wang; Lixia Diao; Li Shen; You Hong Fan; David P Molkentine; Beth M Beadle; Raymond E Meyn; Jeffrey N Myers; John V Heymach
Journal:  Clin Cancer Res       Date:  2016-04-01       Impact factor: 12.531

7.  Integrin-β5 and zyxin mediate formation of ventral stress fibers in response to transforming growth factor β.

Authors:  Anna Bianchi-Smiraglia; Dimiter Kunnev; Michelle Limoge; Amy Lee; Mary C Beckerle; Andrei V Bakin
Journal:  Cell Cycle       Date:  2013-09-13       Impact factor: 4.534

Review 8.  Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.

Authors:  Kyu Sic You; Yong Weon Yi; Jeonghee Cho; Jeong-Soo Park; Yeon-Sun Seong
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

9.  Prognostic Significance of Focal Adhesion Kinase in Node-Negative Breast Cancer.

Authors:  Katrin Almstedt; Isabel Sicking; Marco J Battista; Shangou Huangfu; Anne-Sophie Heimes; Veronika Weyer-Elberich; Annette Hasenburg; Marcus Schmidt
Journal:  Breast Care (Basel)       Date:  2017-10-30       Impact factor: 2.860

10.  Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways.

Authors:  A Bianchi-Smiraglia; S Paesante; A V Bakin
Journal:  Oncogene       Date:  2012-07-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.